1Mulatero P, Stowasser M, Loh KC, et al. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocfinol Metab,2004,89:1045-1050.
2Rossi GP, Bemini G, Caliumi G, et al. A prospective study of the preva- lence of primary aldosteronism in 1125 hypertensive patients. J Am Coll C ardiol, 2006,48 : 2293 -2300.
3Schurman S J, Shoemaker LR. Bartter and Gitelman syndromes. Adv Pe- diatr, 2000,47 : 223 -248.
4Mazzuco TL, Bourdeau I, Lacroix A. Adrenal incidentalomas and sub- clinical Cushing's syndrome: diagnosis and treatment. Curt Opin Endo- crinol Diabetes Obes,2009,16:203-210.
5Lin SH, Lin YF. Propranolol rapidly reverses paralysis, hypokalemia, and hypophosphatemia in thyrotoxic periodic paralysis. Am J Kidney Dis, 2001,37 : 620-623.
6Magsino CH Jr, Ryan AJ Jr. Thyrotoxic periodic paralysis. South Med J, 2000,93:996-1003.
7Elisaf MS, Tomos PP, Milionis H J, et al. Prerenal azotemia in a diabetic patient with hyporeninemic hypoaldosteronism and autonomic neuropa- thy. Diabetes Metab, 1999,25 : 344-346.
8Simon DB, Nelson-Williams C, Bia MJ, et al. Gitelman's variant of Bartter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-CI cotransporter[ J]. Nat Genet, 1996,12( 1 ) :24-30.
9Seyberth HW. An improved terminology and classification of Bartter- like syndromes [ J ]. Nat Clin Pract Nephrol, 2008,4 (10) : 560-567.
10Kim YK, Song HC, Kim YS, et al. Acquired gitelman syndrome J.ElectrolyteBloodPress.2009.7(1):5-8.
